Conduit Pharmaceuticals Inc. has announced the scheduling of its virtual annual meeting of stockholders to be held on December 18, 2024. The meeting will address several key proposals, including the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the adoption of an amendment for a reverse stock split of the company's common stock. The reverse stock split proposal aims to consolidate issued shares into a lesser number by a ratio of not less than 1-for-10 and not more than 1-for-100, with the exact ratio to be determined by the Board. This move is intended to increase the per-share price of the company's stock, potentially...Show More

Conduit Pharmaceuticals Inc. has announced the scheduling of its virtual annual meeting of stockholders to be held on December 18, 2024. The meeting will address several key proposals, including the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the adoption of an amendment for a reverse stock split of the company's common stock. The reverse stock split proposal aims to consolidate issued shares into a lesser number by a ratio of not less than 1-for-10 and not more than 1-for-100, with the exact ratio to be determined by the Board. This move is intended to increase the per-share price of the company's stock, potentially avoiding delisting from the Nasdaq and attracting more investors and analysts. The meeting will also allow for the transaction of other matters that may properly come before the meeting. Only stockholders of record as of October 25, 2024, are entitled to notice of and to vote at the meeting. The company has emphasized the importance of stockholder votes and has provided instructions for voting by internet or by mail.